Remy Leigh Brim Mason is named as a lobbyist on federal disclosure filings for 58 clients through Bgr Government Affairs. The most recent filing naming them posted in October 2026. Issues reported include Health Issues, Pharmacy, Food Industry (safety, labeling, etc.) and Taxation/Internal Revenue Code.
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| STRYKER CORPORATION | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| RECESS | BGR GOVERNMENT AFFAIRS | Q3 2026 | Beverage Industry |
| BREAKTHROUGH T1D (F/K/A JDRF) | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| GRADY HEALTH SYSTEM | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| VAXCYTE, INC. | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| NYU LANGONE HEALTH | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| ACADEMY OF NUTRITION AND DIETETICS | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| PROLACTA BIOSCIENCE, INC. | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| PTC THERAPEUTICS | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| A PLACE FOR MOM, INC. | BGR GOVERNMENT AFFAIRS | Q3 2026 | Government Issues |
| BAYER CORPORATION | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| AMERICAN SOCIETY OF GENE AND CELL THERAPY | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| WALGREEN CO. | BGR GOVERNMENT AFFAIRS | Q3 2026 | Pharmacy |
| EDWARDS LIFESCIENCES LLC | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| BIOTECHNOLOGY INNOVATION ORGANIZATION | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| CARDINAL HEALTH | BGR GOVERNMENT AFFAIRS | Q3 2026 | Taxation/Internal Revenue Code, Trade (domestic/foreign), Health Issues |
| ADVOCATE HEALTH | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues, Budget/Appropriations |
| NEUROCRINE BIOSCIENCES, INC. | BGR GOVERNMENT AFFAIRS | Q3 2026 | Pharmacy |
| PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION | BGR GOVERNMENT AFFAIRS | Q3 2026 | Pharmacy |
| ADVANCED MEDICAL TECHNOLOGY ASSOCIATION | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| BIOMARIN PHARMACEUTICAL INC. | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| ALKERMES, INC. | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| HEARTLAND FOOD PRODUCTS GROUP | BGR GOVERNMENT AFFAIRS | Q3 2026 | Food Industry (safety, labeling, etc.), Health Issues |
| NOVARTIS | BGR GOVERNMENT AFFAIRS | Q3 2026 | Medicare/Medicaid, Health Issues |
| FRESENIUS MEDICAL CARE NORTH AMERICA (FKA FRESENIUS MEDICAL CARE) | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| THE PROCTER & GAMBLE COMPANY | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| ASSOCIATION FOR RESPONSIBLE HEALTHCARE INVESTMENT | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| REGENERON PHARMACEUTICALS, INC. | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| SARGENTO FOODS INC. | BGR GOVERNMENT AFFAIRS | Q3 2026 | Food Industry (safety, labeling, etc.) |
| PFIZER, INC | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| AMGEN INC. | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | BGR GOVERNMENT AFFAIRS | Q3 2026 | Education, Medical/Disease Research/Clinical Labs |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | BGR GOVERNMENT AFFAIRS | Q3 2026 | Pharmacy |
| GLAXOSMITHKLINE, INC | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| PHI HEALTH, LLC, D/B/A PHI AIR MEDICAL | BGR GOVERNMENT AFFAIRS | Q3 2026 | Insurance, Health Issues |
| ORCA BIO | BGR GOVERNMENT AFFAIRS | Q3 2026 | Medical/Disease Research/Clinical Labs |
| WK KELLOGG CO (FKA KELLOGG COMPANY) | BGR GOVERNMENT AFFAIRS | Q3 2026 | Food Industry (safety, labeling, etc.) |
| NUVATION BIO INC. | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| UNILEVER | BGR GOVERNMENT AFFAIRS | Q3 2026 | Food Industry (safety, labeling, etc.), Taxation/Internal Revenue Code, Tariff (miscellaneous tariff bills) |
| STAMFORD HEALTH | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| THE CHILDREN'S HOSPITAL OF PHILADELPHIA | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| THE REGENTS OF THE UNIVERSITY OF MICHIGAN | BGR GOVERNMENT AFFAIRS | Q3 2026 | Education |
| FEDERATION OF AMERICAN HOSPITALS | BGR GOVERNMENT AFFAIRS | Q3 2026 | Medicare/Medicaid, Health Issues |
| ALLIANCE FOR REGENERATIVE MEDICINE | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| REAL TIME MEDICAL SYSTEMS | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| FAIRMOUNT FUNDS MANAGEMENT LLC | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| FINDHELP | BGR GOVERNMENT AFFAIRS | Q3 2026 | Health Issues |
| ACCUMULUS SYNERGY, INC. | BGR GOVERNMENT AFFAIRS | Q4 2025 | Health Issues |
| GLOBAL KRATOM COALITION | BGR GOVERNMENT AFFAIRS | Q4 2025 | Health Issues |
| LOCKTON MANAGEMENT, LLC | BGR GOVERNMENT AFFAIRS | Q4 2025 | Health Issues |
| CHARLES RIVER LABORATORIES | BGR GOVERNMENT AFFAIRS | Q4 2025 | Animals, Pharmacy |
| VIAL | BGR GOVERNMENT AFFAIRS | Q3 2025 | Health Issues |
| EVERYONE MEDICINES | BGR GOVERNMENT AFFAIRS | Q3 2025 | Health Issues |
| ADVANCING MENTAL HEALTH FOR MILITARY FAMILIES, LLC | BGR GOVERNMENT AFFAIRS | Q3 2025 | Defense, Veterans, Health Issues |
| ABIOMED INC | BGR GOVERNMENT AFFAIRS | Q3 2025 | Health Issues |
| BIOMERIEUX, INC. | BGR GOVERNMENT AFFAIRS | Q1 2025 | Health Issues |
| NASSAU HEALTH SYSTEM CORP. | BGR GOVERNMENT AFFAIRS | Q1 2025 | Health Issues |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 48 | 1 |
| 2025 | 52 | 1 |
| Year | Items | Total |
|---|---|---|
| 2026 | 64 | $114K |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Remy Leigh Brim Mason. See the Capitol Clarity rankings and method.